Univest
Univest
  • Markets

AVIENCE BIOMEDICALS LTD (AVIENCE-SM): AVIENCE BIOMEDICALS Share Price rises 11.01% as stock trades at Rs 385

  • September 9, 2026
  • Posted by: Harsh Piplani
  • Category: News
No Comments
AVIENCE BIOMEDICALS Share Price
AVIENCE BIOMEDICALS LTD (AVIENCE-SM) share price rose to Rs 385 today, up 11.01% from the previous close. Market cap was Rs 184.49 crore.

AVIENCE BIOMEDICALS Share Price is in focus today after the stock rose 11.01% to Rs 385, up from the previous close of Rs 346.8, while market capitalisation stood at Rs 184.49 Cr. The latest Univest figures confirm a clear price rise in the Indian stock market, but they do not establish a company-specific catalyst. That makes this a price action-led stock news event rather than a story with a verified trigger. For investors tracking AVIENCE BIOMEDICALS Share Price Today, the near-term focus is on how the move compares with the company’s valuation, healthcare sector context and the day’s trading range as of 11 September 2026 at 2:52:47 PM IST.

The stock opened at Rs 356.1, moved between Rs 322 and Rs 387.45, and was last trading close to the day’s upper end. That keeps AVIENCE BIOMEDICALS Share Price on the list of stocks rising today and among the market movers attracting attention on Univest. The move is meaningful because it combines an intraday gain with a relatively small market cap, which often draws sharper search interest for AVIENCE BIOMEDICALS Stock News, AVIENCE BIOMEDICALS Share News and AVIENCE BIOMEDICALS Share Price Live updates.

Table of Contents

Toggle
  • AVIENCE BIOMEDICALS Share Price Today: Price Action Analysis
  • AVIENCE BIOMEDICALS LTD (AVIENCE-SM) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching AVIENCE BIOMEDICALS
  • About AVIENCE BIOMEDICALS
  • Frequently Asked Questions
    • Why is AVIENCE BIOMEDICALS Share Price rising today?
    • What is AVIENCE BIOMEDICALS Share Price today?
    • How much did AVIENCE BIOMEDICALS stock rise today?
    • What is AVIENCE BIOMEDICALS market cap now?
    • Is AVIENCE BIOMEDICALS expensive on valuation?
    • What do AVIENCE BIOMEDICALS EPS and book value show?
    • How do AVIENCE BIOMEDICALS ROE and ROCE compare with peers?
    • Should investors track AVIENCE BIOMEDICALS Share Price on Univest?
  • Track AVIENCE BIOMEDICALS Share Price on Univest

AVIENCE BIOMEDICALS Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 385
Previous Close Rs 346.8
Today's Move Rs 38.2 (+11.01%)
Open Rs 356.1
High Rs 387.45
Low Rs 322
Turnover Rs 3.4 crore
Market Capitalisation Rs 184.49 crore
Market Cap Category Micro Cap

AVIENCE BIOMEDICALS LTD (AVIENCE-SM) rose to Rs 385 from the previous close of Rs 346.8, a move of Rs 38.2 or 11.01%. The stock opened at Rs 356.1, reached a high of Rs 387.45, recorded a low of Rs 322.

AVIENCE BIOMEDICALS Share Price Today reflects an 11.01% rise, with the stock adding Rs 38.2 from the previous close of Rs 346.8 to Rs 385. The session range of Rs 322 to Rs 387.45 shows that the price first moved lower before recovering strongly, and the latest level remained near the day’s high. Turnover stood at Rs 3.4 Cr, which helps frame the intensity of trading interest without changing the core reading of today’s price action. In short, AVIENCE BIOMEDICALS Share Price is being driven by a sharp intraday share price rise that has placed it among the top gainers today and kept AVIENCE BIOMEDICALS Stock News in focus for market participants.

AVIENCE BIOMEDICALS LTD (AVIENCE-SM) Fundamental Analysis

Metric Value
Market Capitalisation Rs 184.49 crore
P/E Ratio 21.73x
P/B Ratio 7.85x
ROE 49.9%
ROCE 34.16%
EPS Rs 15.96
Book Value Per Share Rs 44.18
Dividend Yield 0%

AVIENCE BIOMEDICALS LTD (AVIENCE-SM) fundamental metrics show P/E 21.73x, P/B 7.85x, ROE 49.9%, ROCE 34.16%. These figures provide context only and are not a buy or sell signal.

AVIENCE BIOMEDICALS LTD has a market capitalisation of Rs 184.49 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 21.73x, P/B at 7.85x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 49.9% and ROCE of 34.16%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 15.96, book value per share of Rs 44.18, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.82x, median ROE of 15.01%, median ROCE of 16.41%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Medical Equipment/Supplies/Accessories
Benchmark Scope same industry
Company P/E Ratio 21.73x
Benchmark Median P/E 31.82x
Benchmark Average P/E 88.87x
Benchmark P/E Range 7.35x to 1,004.34x
Company P/B Ratio 7.85x
Benchmark Median P/B 3.37x
Company ROE 49.9%
Benchmark Median ROE 15.01%
Company ROCE 34.16%
Benchmark Median ROCE 16.41%
Company Market Capitalisation Rs 184.49 crore
Benchmark Median Market Cap Rs 187.15 crore

AVIENCE BIOMEDICALS LTD (AVIENCE-SM) is classified under sector: Healthcare and industry: Medical Equipment/Supplies/Accessories.

AVIENCE BIOMEDICALS LTD (AVIENCE-SM) has a P/E ratio of 21.73x, which is below the benchmark median of 31.82x, a difference of -31.71%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

AVIENCE BIOMEDICALS LTD (AVIENCE-SM) has a ROE of 49.9%, which is above the benchmark median of 15.01%, a difference of +232.45%. AVIENCE BIOMEDICALS LTD (AVIENCE-SM) has a ROCE of 34.16%, which is above the benchmark median of 16.41%, a difference of +108.17%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
LENSKART SOLUTIONS LTD LENSKART 1,20,716.54 183.97 13.49 6.85 12.55
Poly Medicure Ltd. POLYMED 17,472.69 56.22 5.57 10.94 14.05
Q-LINE BIOTECH LIMITED QLINE 1,576.29 29.29 0 26.05 23
3B Blackbio Dx Ltd. 3BBLACKBIO 1,263.45 22.36 4.43 19.41 26.03
LAXMI DENTAL LIMITED LAXMIDENTL 1,102.79 36.1 4.41 21.4 24.97

AVIENCE BIOMEDICALS LTD (AVIENCE-SM) has a P/E ratio of 21.73x compared with the displayed peer median of 36.1x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 49.9% compares with a peer median of 19.41% across the companies shown in the table. ROCE stood at 34.16% versus the displayed peer median of 23%, providing a capital-efficiency comparison. AVIENCE BIOMEDICALS LTD (AVIENCE-SM) has a market capitalisation of Rs 184.49 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching AVIENCE BIOMEDICALS

  • AVIENCE BIOMEDICALS Share Price rose 11.01% to Rs 385, making it a notable price action event today.
  • The stock traded between Rs 322 and Rs 387.45, with the latest level near the day’s upper end.
  • Market capitalisation of Rs 184.49 Cr keeps the move visible in small-cap healthcare names.
  • P/E of 21.73 and P/B of 7.85 create a mixed valuation picture for AVIENCE BIOMEDICALS Share Price.
  • ROE of 49.9 and ROCE of 34.16 keep AVIENCE BIOMEDICALS Fundamental Analysis in focus for Univest readers.

About AVIENCE BIOMEDICALS

AVIENCE BIOMEDICALS LTD operates in the Healthcare sector and the Medical Equipment/Supplies/Accessories industry. The latest Univest data places the company within a small market-cap bracket, yet its return ratios point to an efficient operating profile relative to many listed peers. Investors looking at AVIENCE BIOMEDICALS Share Price usually follow how the business is positioned within the broader healthcare supply chain and whether its earnings quality continues to support the current valuation.

For readers searching AVIENCE BIOMEDICALS Stock News or AVIENCE BIOMEDICALS Company News, the core takeaway is straightforward: the company sits in a sector where benchmark valuations and return ratios vary widely, and the stock’s own numbers currently stand out more for profitability than for size. That is why AVIENCE BIOMEDICALS Share Price remains part of broader healthcare stock updates on Univest.

Frequently Asked Questions

Why is AVIENCE BIOMEDICALS Share Price rising today?

Ans. AVIENCE BIOMEDICALS Share Price rose 11.01% to Rs 385, but the latest Univest data does not establish a company-specific catalyst. The move is confirmed by today’s price action and market cap of Rs 184.49 Cr.

What is AVIENCE BIOMEDICALS Share Price today?

Ans. AVIENCE BIOMEDICALS Share Price today is Rs 385, compared with the previous close of Rs 346.8. The stock is trading higher by Rs 38.2, which keeps it in the spotlight among stocks rising today.

How much did AVIENCE BIOMEDICALS stock rise today?

Ans. AVIENCE BIOMEDICALS stock rose by 11.01% today. The move lifted the share price from Rs 346.8 to Rs 385 and pushed the company into the day’s notable gainers in the Indian stock market.

What is AVIENCE BIOMEDICALS market cap now?

Ans. AVIENCE BIOMEDICALS market cap stands at Rs 184.49 Cr. That places the company in the small-cap range and helps explain why AVIENCE BIOMEDICALS Share Price can move sharply in a single trading day.

Is AVIENCE BIOMEDICALS expensive on valuation?

Ans. AVIENCE BIOMEDICALS trades at a P/E of 21.73 and P/B of 7.85. The P/E is below the same-industry median, while the P/B is above it, so the valuation picture is mixed rather than one-sided.

What do AVIENCE BIOMEDICALS EPS and book value show?

Ans. AVIENCE BIOMEDICALS has EPS of Rs 15.96 and book value of Rs 44.18. EPS reflects earnings attributable to each share, while book value shows the accounting net worth behind each share.

How do AVIENCE BIOMEDICALS ROE and ROCE compare with peers?

Ans. AVIENCE BIOMEDICALS reports ROE of 49.9 and ROCE of 34.16, both above the same-industry medians. Those return ratios compare well with the peer set and support investor attention to the stock.

Should investors track AVIENCE BIOMEDICALS Share Price on Univest?

Ans. Yes, investors tracking AVIENCE BIOMEDICALS Share Price can use Univest for price updates, valuation metrics, sector benchmarks and peer comparison. Today’s rise makes the stock relevant for market watchers seeking factual stock news.

Track AVIENCE BIOMEDICALS Share Price on Univest

Use AVIENCE BIOMEDICALS LTD (AVIENCE-SM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Investors can track AVIENCE BIOMEDICALS Share Price on Univest for live price updates, market cap context, fundamental ratios, sector comparison, peer comparison and company insights. Univest also helps users follow AVIENCE BIOMEDICALS Share Price Today alongside related stock news, share price update pages and market-level context in one place.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).



Author: Harsh Piplani
I am Harsh Piplani, an Assistant Content Manager with over 5 years of experience in crafting impactful, result-driven content. I hold a B.Com (Hons) degree and have worked across diverse industries, including education, fintech, healthcare, jewellery, and more. I specialise in content strategy, SEO, and optimisation, ensuring that every piece I create is not just well-written but also well-ranked. I believe content should do more than fill space so as to drive traffic, build authority, and support business growth. I enjoy turning complex ideas into clear, engaging narratives, and, as I like to say, I know how to spin words like a web to influence, structured, strategic, and impossible to ignore. For me, great content sits at the intersection of creativity and performance.

Leave a Reply Cancel reply